How has been the historical performance of Sotac Pharma.?

Answer:The historical performance of Sotac Pharma shows a trend of increasing net sales and profitability over the years, with a notable rise in both operating and net profits.

Breakdown:
Sotac Pharma's net sales have shown a steady increase from INR 28.60 crore in March 2020 to INR 96.99 crore in March 2025, despite a slight decline to INR 103.83 crore in March 2024. The total operating income followed a similar trajectory, reaching INR 96.99 crore in March 2025. The company's operating profit (PBDIT) also improved significantly, rising from INR 1.56 crore in March 2021 to INR 17.55 crore in March 2025, reflecting an operating profit margin increase from 2.97% to 14.07% over the same period. Profit before tax surged to INR 11.12 crore in March 2025, up from a loss of INR 2.06 crore in March 2021, while profit after tax reached INR 9.28 crore in March 2025, compared to a loss of INR 2.37 crore in March 2021. The company's total assets grew from INR 34.70 crore in March 2021 to INR 123.03 crore in March 2025, with total liabilities also increasing from INR 34.70 crore to INR 123.03 crore during the same period. Cash flow from operating activities remained negative but improved from -INR 16.00 crore in March 2024 to -INR 4.00 crore in March 2025. Overall, Sotac Pharma's financial performance indicates a positive trend in revenue and profitability, alongside a significant increase in total assets and liabilities.